4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001470831-26-000175
Chief Financial Officer gave up 17,244 shares (to pay taxes)
- Chief Financial Officer acquired 240,000 shares (grant or award)
- Chief Financial Officer acquired 34,700 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Adams Kendra · Chief Financial Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-13 | Grant or award : show line 1 in the form | +240,000 | 402,342 | D | ||
| 2026-02-13 | Exercise or conversion : show line 2 in the form | +3,750 | 402,342 | D | ||
| 2026-02-13 | Shares withheld for taxes : show line 3 in the form | −1,863 | $1.89 | $3,521 | 400,479 | D |
| 2026-02-14 | Exercise or conversion : show line 4 in the form | +30,950 | 400,479 | D | ||
| 2026-02-14 | Shares withheld for taxes : show line 5 in the form | −15,381 | $1.89 | $29,070 | 385,098 | D |
Loading xslF345X05/wk-form4_1771452283.xml…